DAB2 and cancer: Subsequent quantitative reverse transcription PCR and immunoblot analysis at a subset of cancer cell lines, such as DMS114 or K562 cells, induced transcription as well as protein expression levels of DAB2 in RepID-depleted conditions (Fig. 1D, E).